Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous
PrescriptionHandelsnamen: K-Phos No. 2
About This Medication
DESCRIPTION Each tablet contains potassium acid phosphate 305 mg and sodium acid phosphate, anhydrous, 700 mg. Each tablet yields approximately 250 mg of phosphorus, 88 mg of potassium or 2.3 mEq and 134 mg of sodium or 5.8 mEq. Inactive ingredients: Lactose, magnesium stearate, microcrystalline cellulose, povidone, purified water, sodium starch glycolate, stearic acid, talc, brown coating (FD&C Blue No. 2, FD&C Red No. 40, FD&C Yellow No. 6, hypromellose, polyethylene glycol, polydextrose, titanium dioxide, triacetin).
Wirkstoffe
| Wirkstoff | Stärke |
|---|---|
| Potassium Phosphate, Monobasic | - |
| Sodium Phosphate, Monobasic, Anhydrous | - |
Indikationen und Anwendung
Dosierung und Verabreichung
Side Effects Overview
Kontraindikationen
CONTRAINDICATIONS This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.
Frequently Asked Questions
INDICATONS AND USAGE K-PHOS® No. 2 is a highly effective urinary acidifier for use in patients with elevated urinary pH. This product helps keep calcium soluble and reduces odor and rash caused by ammoniacal urine. Also, by acidifying the urine, it increases the antibacterial activity of methenamine mandelate and methenamine hippurate.
DOSAGE AND ADMINISTRATION One tablet four times daily with a full glass of water. When the urine is difficult to acidify, administer one tablet every two hours not to exceed 8 tablets in a 24-hour period.
CONTRAINDICATIONS This product is contraindicated in patients with infected phosphate stones, in patients with severely impaired renal function (less than 30% of normal) and in the presence of hyperphosphatemia.
Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous is a prescription medication. You will need a valid prescription from a licensed healthcare provider.
Similar Tablet Products
Browse all Tablet products →References & Data Sources
- • DailyMed — Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous drug label (National Library of Medicine)
- • openFDA — Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous label data (U.S. Food & Drug Administration)
- • RxNorm — RXCUI 209224 (NLM Normalized Drug Names)
- • NDC Directory — Potassium Phosphate, Monobasic And Sodium Phosphate, Monobasic, Anhydrous (FDA National Drug Code)
Medizinischer Haftungsausschluss
Die Informationen auf dieser Seite dienen ausschließlich zu Bildungszwecken und sollten nicht als Ersatz für professionellen ärztlichen Rat, Diagnose oder Behandlung verwendet werden.
Wenden Sie sich bei Fragen zu einem medizinischen Zustand oder einem Arzneimittel stets an Ihren Arzt oder einen anderen qualifizierten Angehörigen der Gesundheitsberufe.
Datenquellen: DailyMed (NLM), openFDA, MFDS